Widespread screening for islet autoantibodies reduces the occurrence of diabetic ketoacidosis

Widespread screening for islet autoantibodies reduces the occurrence of diabetic ketoacidosis

Widespread screening for islet autoantibodies reduces the occurrence of diabetic ketoacidosis

JDRF, the leading global organization funding type 1 diabetes research, today announced new research that found widespread screening for islet autoantibodies reduced the occurrence of life-threatening diabetic ketoacidosis among children with pre-symptomatic T1D.